hypoglycemia

Search with Google Search with Bing
Information
Disease name
hypoglycemia
Disease ID
DOID:9993
Description
"A glucose metabolism disease that is characterized by abnormally low levels of blood glucose." [url:https\://www.niddk.nih.gov/health-information/diabetes/overview/preventing-problems/low-blood-glucose-hypoglycemia]
Disease area statistics
Chromosome band
Gene symbol Chromosome Start Stop The number of variant
MPV17 2 27,309,492 27,323,097 8
MRPS23 17 57,834,781 57,850,044 4
QRSL1 6 106,629,578 106,668,417 4
Annotation
Genes Mutation Description Source Links
NCT ID Status Phase Summary Start date Completion date
NCT03429946 Active, not recruiting Phase 4 Hypoglycemia and Autonomic Nervous System Function-B July 17, 2013 January 4, 2024
NCT04585191 Active, not recruiting N/A Reducing Treatment Risk in Older Adults With Diabetes November 2, 2020 September 2024
NCT05500352 Active, not recruiting N/A Acute Changes in Plasma Glucose and Cardiovascular Disease in Diabetes July 1, 2022 December 1, 2023
NCT04428723 Active, not recruiting Mechanisms of Hypoglycemia in Patients Without Diabetes August 11, 2020 May 2025
NCT04841304 Active, not recruiting Cardiac Arrhythmia in Patients With End-Stage Renal Disease June 1, 2021 August 2024
NCT03422471 Active, not recruiting N/A Hypoglycemia and Autonomic Nervous System Function- B2 September 25, 2017 October 28, 2024
NCT03406897 Active, not recruiting Phase 1/Phase 2 Pilot Study of OMEGA-3 and Vitamin D in High-Dose in Type I Diabetic Patients July 23, 2018 December 2026
NCT04430582 Active, not recruiting Cognition in Patients With Hypoglycemia, Without Diabetes August 4, 2020 April 30, 2023
NCT04428866 Active, not recruiting Mechanisms of Post-Bariatric Hypoglycemia February 26, 2020 September 2024
NCT03215914 Active, not recruiting N/A Hybrid Closed Loop Insulin Delivery System in Hypoglycemia August 1, 2017 December 31, 2024
NCT03608163 Active, not recruiting Phase 4 Novel Approach for the Prevention of Hypoglycemia Associated Autonomic Failure (HAAF) August 10, 2018 December 15, 2023
NCT03079921 Active, not recruiting Early Phase 1 Adrenergic System in Islet Transplantation January 20, 2017 December 31, 2024
NCT03481530 Active, not recruiting Role of CGMS Usage in Predicting Risk for Hypoglycemia October 1, 2018 September 30, 2025
NCT05919927 Active, not recruiting Diabetes and Cognitive Functions in Middle Age June 7, 2018 December 30, 2024
NCT05540132 Active, not recruiting N/A Slow Digestible Carbohydrates and Exercise in Adolescents With Type 1 Diabetes July 15, 2023 June 2025
NCT02213003 Active, not recruiting Phase 1/Phase 2 Allogeneic Islet Cells Transplanted Onto the Omentum September 2014 May 2026
NCT04614168 Active, not recruiting N/A Maximising Time With a Normal Blood Glucose to Restore the Glucagon Response in Type 1 Diabetes July 26, 2021 December 26, 2025
NCT01606475 Available Islet Transplant for Type 1 or Surgical Diabetes
NCT00589589 Completed Phase 1 Computer Decision Support to Achieve Glycemic Control in the ICU January 2008 January 2011
NCT00615368 Completed N/A Treatment With Erythropoietin and Cognition During Hypoglycaemia May 2008 December 2010
NCT00641407 Completed Phase 4 Bedtime Insulins and Oral Antihyperglycemic Drugs in Type 2 Diabetes January 2007 March 2008
NCT00706693 Completed N/A Skittles(TM) Effective for Treating Hypoglycemia in Children With Type 1 Diabetes August 2003 September 2006
NCT00745186 Completed Phase 1 Pharmacokinetics (PK) and Pharmacodynamics (PD) of Mayne Glucagon for Injection Compared With Glucagen® (Novo Nordisk) in Healthy Volunteers August 2007 March 2008
NCT00802971 Completed N/A Idiopathic Reactive Hypoglycaemia and Treatment With Fructo-Oligosaccharide December 2008 June 2009
NCT00804297 Completed Phase 3 Octreotide for the Treatment of Sulfonylurea-Associated Hypoglycemia June 2005 January 2007
NCT00810420 Completed EEG-Changes During Insulininduced Hypoglycemia in Type 1 Diabetes February 2007 April 2008
NCT00826007 Completed Associated Factors in Perioperative Hypoglycemia in Patients With Diabetes January 2009 July 2011
NCT00843609 Completed N/A International Navigator Hypoglycaemia Study October 2008 January 2010
NCT00882050 Completed Phase 1/Phase 2 Intravenous Exenatide (Byetta) During Surgery March 2009 April 2016
NCT00882492 Completed Phase 1 GLP 1 for Intraoperative Glycemic Control December 2008 May 2011
NCT00937079 Completed Whole Body 111In-exendin-4 Imaging Study in Insulinoma Patients November 2007 December 2011
NCT00998374 Completed Comparison Between Pyloric Preserving and Non-Pyloric Preserving Bariatric Surgery With Glucose Challenge September 2009 April 2013
NCT01005342 Completed N/A Influence of Dietary Fiber-rich Meals on Gene Expression and Postprandial Glucose and Lipid Response May 2007 June 2007
NCT01013402 Completed Phase 4 Investigating the Accuracy of the Home Glucose Monitors in Hypoglycemia December 2008 August 2009
NCT01043042 Completed Identification of Inpatients at Risk for Poor Glycemic Control January 2010 September 2014
NCT01116180 Completed N/A Cognitive Function and Electrocardiogram (ECG) During Hypoglycemia and Blockade of the Renin-angiotensin System April 2010 February 2013
NCT01147276 Completed Phase 4 Vildagliptin and the Glucagon Response to Hypoglycemia in Type 1 Diabetes September 2010 December 2011
NCT01176656 Completed Hypoglycemia: Physician and Patient Perspectives September 2010 December 2010
NCT01272583 Completed N/A Dipeptidyl Peptidase-4 Inhibitors and Alpha-cell Recovery March 2011 October 2012
NCT01283126 Completed N/A Blood/Interstitial Glucose Measurements and Cognitive Function During Hypoglycemia and Recovery January 2011 October 2015
NCT01383889 Completed N/A Acute Maternal and Fetal Effects of Exercise in Pregnancy December 2011 December 2012
NCT01394627 Completed N/A Hypoglycemia and the Mineralocorticoid Receptor January 2011 August 2016
NCT01409382 Completed N/A Maternal Lifestyle and Neonatal Hypoglycemia March 2011 October 2015
NCT01462227 Completed N/A Effect of Naltrexone on Counterregulatory Mechanisms in Hypoglycemia August 2011 October 2013
NCT01556594 Completed Phase 2 Safety and Efficacy of a Novel Glucagon Formulation in Type 1 Diabetic Patients Following Insulin-induced Hypoglycemia March 2012 July 2012
NCT01563887 Completed N/A Identifying Driving Risk Factors in Type 1 Diabetes and Their Reduction Via Internet Program (DiabetesDriving.Com) February 2012 October 2014
NCT00006508 Completed N/A Disorders of Systemic Glucose Balance
NCT00264641 Completed N/A The Impact of Renin-angiotensin System on Brain Activation During Hypoglycaemia in Healthy Men, a PET Study January 2006 February 2008
NCT00265473 Completed Phase 1/Phase 2 MGA031, Sirolimus and Tacrolimus in Islet Transplantation November 2005 June 2010
NCT00285194 Completed Phase 1/Phase 2 hOKT3γ1 (Ala-Ala) Combined With Sirolimus and Delayed Tacrolimus in Type 1 Diabetic Islet Allograft Recipients April 2000 January 2004
NCT00285233 Completed Phase 1/Phase 2 Delayed Mycophenolate Mofetil in Single-Donor Islet Allotransplantation in Type 1 Diabetes September 2000 March 2005
NCT00286624 Completed Phase 1/Phase 2 Anti-Thymocyte Globulin, Cyclosporine, and RAD in Islet Transplantation March 2003 August 2006
NCT00292578 Completed Phase 1/Phase 2 NAET® Testing Devices in Detection of Hypersensitivity to Cane Sugar January 2005 January 2006
NCT00322660 Completed N/A Adrenaline Injections to Children Born at Elective CS June 2006 June 2007
NCT00351234 Completed Carnitine Levels and Carnitine Supplementation in Type I Diabetes October 2004 April 2007
NCT00373854 Completed Study of How Low Blood Sugar Affects the Way Blood Vessels Work September 2005 September 2006
NCT00434772 Completed Phase 2 Glucagon in the Treatment of Hypoglycemia in Newborn Infants of Diabetic Mothers December 2007 May 2009
NCT00446264 Completed Phase 2 Islet Allotransplantation With Steroid Free Immunosuppression May 2003 February 2009
NCT00453375 Completed Phase 1 Phase 1 Study of BHT-3021 in Subjects With Type 1 Diabetes Mellitus October 2006 May 2011
NCT00467688 Completed N/A Effect of Continuous Glucose Monitoring on Course of Glucose in Type 1 Diabetes February 2007 July 2007
NCT00554281 Completed Phase 3 Using Glucose Sensors to Prevent Hypoglycemia October 2006 August 2008
NCT00575783 Completed Impact of Hypoglycemia Unawareness on Brain Metabolism Cognition in T1DM August 2005 August 2008
NCT00580710 Completed Investigation Into the Effects Upon Brain Response to Change in Circulating Glucose Levels in Diabetes Mellitus August 2001 November 1, 2018
NCT02403648 Completed Phase 1 Pharmacokinetics and Pharmacodynamics of BIOD-961 vs. Marketed Glucagons November 2014
NCT02423980 Completed Phase 2 G-Pen™ for Hypoglycemia Rescue in T1D Patients April 2015 June 2015
NCT02424500 Completed N/A Multi-Center Study Comparing Efficacy and Safety of Frequently Modified Insulin Therapy January 2015 June 30, 2017
NCT02459938 Completed Phase 1 Safety and Efficacy of ZP-Glucagon to Injectable Glucagon for Hypoglycemia January 2015 October 2015
NCT02471040 Completed Phase 1 Brain Ketone Metabolism in Type 1 Diabetes May 14, 2013 April 4, 2022
NCT02523222 Completed N/A Prophylactic Dextrose Gel for Newborns at High-risk for Hypoglycemia July 2016 October 2016
NCT02527993 Completed Phase 4 Treatment of Hypoglycemia Following Gastric Bypass Surgery October 2015 April 8, 2017
NCT02578498 Completed Phase 4 Glucagon Efficiency After High and Low Carbohydrate Diet October 2015 July 2016
NCT02656069 Completed Phase 3 Safety and Efficacy of G-Pen Compared to Lilly Glucagon for Hypoglycemia Rescue in Adult Type 1 Diabetics March 15, 2017 September 25, 2017
NCT02660008 Completed Phase 2 Single Doses of ZP4207 Adm. sc to Hypoglycemic TD1 pt. to Describe the PK and PD of ZP4207 as Comp. to Marketed Glucagon January 2016 June 2016
NCT02666521 Completed Hypoglycaemia in People With Type 2 Diabetes in Primary Care July 20, 2012 June 30, 2017
NCT02687893 Completed N/A Effect of Hypoglycemia on Sleep February 2016 July 18, 2018
NCT02690168 Completed Testing Glial Pathways to HAAF in Human Subjects Using Carbon 13 Magnetic Resonance Spectroscopy February 2016 July 2017
NCT02714972 Completed Phase 2 Reduction of Nocturnal Hypoglycemia and Hyperglycemia in the Home Using Predictive Algorithms, Pump Suspension, and Insulin Dosing in Children and Young Adolescents May 2016 May 2017
NCT02733588 Completed Phase 2 Delivery of G-Pump™ (Glucagon Infusion) From an OmniPod® to Prevent Hypoglycemia in Post-Bariatric Surgery Patients March 2016 June 1, 2017
NCT02735031 Completed Phase 2/Phase 3 Exenatide and Impaired Hypoglycaemic Awareness in Type 1 Diabetes February 21, 2017 April 9, 2018
NCT02772718 Completed Phase 2 An Open-Label Study of XOMA 358 in Patients With Hypoglycemia After Gastric Bypass Surgery April 2016 May 2021
NCT02866435 Completed Early Phase 1 Identifying the Brain Substrates of Hypoglycemia Unawareness in Type 1 Diabetes November 2016 December 30, 2019
NCT02871180 Completed N/A Late Night Snack and Insulin Glargine March 2003
NCT02875925 Completed N/A Outcomes Study of MTM in a Medicare ACO December 2015 December 2017
NCT02881060 Completed Phase 4 The Late Effects of Ethanol Intake on the Glucose Response to Subcutaneous Glucagon in Type 1 Diabetes August 2016 January 26, 2017
NCT02898428 Completed Continuous Glucose Monitoring in New Mothers With Type 1 Diabetes April 2016 April 2018
NCT02940873 Completed N/A Hypoglycaemia Awareness Restoration Programme March 9, 2017 April 27, 2021
NCT02966275 Completed N/A Post Bariatric Closed Loop Glucagon Trial September 2016 December 2017
NCT03006510 Completed N/A Hypoglycemia Prediction Model January 2017 June 1, 2018
NCT03014011 Completed N/A Effects of Mild Hypoglycaemia on Cognitive Function in Type 2 Diabetes June 13, 2017 July 24, 2018
NCT03034226 Completed N/A Comparison Between Hypoglycemic Counter Regulatory Responses in Type 1 Diabetics vs Control Subjects February 23, 2017 January 1, 2019
NCT03034798 Completed Suspending Basal Insulin Levels for Exercise in Adults With Type 1 Diabetes January 14, 2015 July 28, 2016
NCT03078491 Completed N/A Technological Advances in Glucose Management in Older Adults March 30, 2017 October 1, 2022
NCT03090451 Completed N/A Exercise Physiology Study May 1, 2017 June 18, 2019
NCT03130101 Completed N/A Insulin Management for Exercise in Patients With Type 1 Diabetes April 3, 2017 February 1, 2018
NCT03182842 Completed N/A FreeStyle Libre FGM During Summer Camp for Children With Type 1 Diabetes June 17, 2017 July 1, 2017
NCT03216226 Completed Phase 3 A Trial to Evaluate the Immunogenicity of Dasiglucagon and GlucaGen in Patients With Type 1 Diabetes Mellitus June 28, 2017 February 13, 2018
NCT03339453 Completed Phase 1 A Study of Nasal Glucagon in Participants With Type 1 Diabetes Mellitus November 10, 2017 January 13, 2018
NCT03353415 Completed N/A Continuous Glucose Monitoring to Reduce Hypoglycemia and Improve Safety After Gastric Surgery February 7, 2019 April 12, 2023
NCT03378635 Completed Phase 3 A Trial to Confirm the Efficacy and Safety of Dasiglucagon in the Treatment of Hypoglycemia in Type 1 Diabetes Subjects December 7, 2017 May 25, 2018
NCT03435198 Completed Biomarkers in Exhaled Breath of Glucose Fluctuation in Type 1 Diabetes March 1, 2018 August 30, 2018
NCT03460899 Completed N/A Impact of Hypoglycaemia in Patients With Diabetes Mellitus Type 2 on Platelet Activation February 12, 2018 June 11, 2018
NCT03482154 Completed Malglycemia in the Pediatric Hematopoietic Stem Cell Transplant Population September 6, 2016 June 30, 2019
NCT03556033 Completed Phase 2 Effect of Dapagliflozin on IAH in T1DM November 23, 2018 December 20, 2019
NCT03665870 Completed N/A Prevention Through Intervention: Telehealth Solution to Deter 911 Calls Due to Hypoglycemia October 1, 2018 July 20, 2020
NCT03667053 Completed Phase 3 Trial to Confirm the Efficacy and Safety of Dasiglucagon in the Treatment of Hypoglycemia in T1DM Children September 28, 2018 June 28, 2019
NCT03688711 Completed Phase 3 Trial to Confirm the Clinical Efficacy and Safety of Dasiglucagon in the Treatment of Hypoglycemia in Subjects With T1DM November 1, 2018 March 11, 2019
NCT03711656 Completed N/A Prediction and Prevention of Nocturnal Hypoglycemia in Persons With Type 1 Diabetes Using Machine Learning Techniques October 10, 2018 April 30, 2019
NCT03725657 Completed Correlation Between Exercise and Insulin Dose in a Camp for Pediatric Type 1 Patients October 29, 2018 September 18, 2019
NCT03734718 Completed N/A The Role of Glucose-Dependent Insulinotropic Polypeptide in the Pathological Glucose Homeostasis Of Type 1 Diabetes June 1, 2019 December 31, 2019
NCT03735225 Completed Phase 1 Evaluation of the Safety, Tolerability and Bioavailability of Dasiglucagon Following Subcutaneous (SC) Compared to IV Administration November 7, 2018 June 24, 2019
NCT03841526 Completed Phase 2 Glucagon Ready-to-Use (RTU) for Prevention of Exercise-Induced Hypoglycemia During Aerobic Exercise in Adults With T1D August 22, 2019 April 2, 2020
NCT03859401 Completed N/A Exercise-Induced Hypoglycemia Prevention in Adults With Type 1 Diabetes Using an Artificial Pancreas April 12, 2019 January 13, 2020
NCT03868657 Completed N/A The Physiological Effects of Human Ether-a-go-go-Related Gene (hERG)Blockade on Metabolism January 28, 2019 March 9, 2020
NCT03895697 Completed Phase 3 A Trial to Compare the Efficacy and Safety of 2 Different Batches of Subcutaneous Dasiglucagon in Patients With T1DM March 26, 2019 July 30, 2019
NCT03956173 Completed Hypoglycemia and Cardiac Arrhythmias in Type 1 Diabetes December 1, 2018 December 1, 2021
NCT03976271 Completed N/A Consequences of Hypoglycaemia on Cardiovascular and Inflammatory Responses August 12, 2019 March 31, 2021
NCT04020445 Completed Simplification of Complex Insulin Regimens With Preserving Good Glycemic Control in Type 2 Diabetes January 1, 2016 January 1, 2022
NCT04025762 Completed N/A 24/7 Closed-loop in Older Subjects With Type 1 Diabetes September 1, 2019 August 20, 2021
NCT04050553 Completed Phase 1 A Study of Tirzepatide in Participants With Type 2 Diabetes Mellitus February 24, 2020 January 25, 2022
NCT04053712 Completed Phase 4 Dual-hormone Closed-loop Glucose Control in Type 1 Diabetes July 16, 2019 March 19, 2021
NCT04177147 Completed N/A Primary Care Clinicians' Responses to a Hypoglycemia Risk Calculator for Diabetes Mellitus in Ambulatory Care January 14, 2016 September 30, 2016
NCT04219514 Completed Investigating Novel Predictions of Hypoglycemia Occurrence in Real-world Models February 10, 2020 March 30, 2021
NCT04304963 Completed Hypo-METRICS: Hypoglycaemia - Measurement, ThResholds and ImpaCtS October 1, 2020 October 31, 2022
NCT04328896 Completed N/A Telemedicine Monitoring of Nocturnal Incidents June 15, 2018 November 30, 2018
NCT04332289 Completed Assessing Insulin Turnover Using an In-vivo Deuterated Water Experiment. July 9, 2020 August 20, 2020
NCT04392843 Completed N/A Effect of Fasting on Insulin-induced Hypoglycemia Counterregulation in Healthy Humans April 12, 2019 May 11, 2023
NCT04422145 Completed N/A Hypoglycemia Requiring Emergency Services Intervention: Patient Characteristics, Outcome and Cardiovascular Risk Profile February 1, 2013 December 18, 2018
NCT04430660 Completed N/A Evaluating Glial Acetate Metabolism as a Biomarker of Hypoglycemic Complications in Diabetic Patients August 19, 2020 May 4, 2022
NCT04449692 Completed Phase 2 Low-dose Dasiglucagon for Prevention of Insulin-Induced Hypoglycemia in People With Type 1 Diabetes July 2, 2020 January 4, 2021
NCT04473001 Completed Wireless Assessment of Respiratory and Circulatory Distress - Continuous Glucose Monitoring June 26, 2020 February 28, 2021
NCT04659330 Completed N/A Lipohypertrophy Monitoring Study June 1, 2018 December 24, 2019
NCT04692623 Completed Phase 1 EFFECTS OF MOXIFLOXACIN AND GEMIFLOXACIN ON BLOOD GLUCOSE AND ECG MORPHOLOGY OF EUGLYCEMICS:A CLINICAL STUDY March 1, 2021 April 1, 2021
NCT04721145 Completed N/A CGM Use in Poorly Controlled Youth With Type 1 Diabetes January 25, 2021 June 28, 2022
NCT04764968 Completed Phase 2 Pen-Administered Low-Dose Dasiglucagon for Prevention and Treatment of Hypoglycemia in People With Type 1 Diabetes April 27, 2021 January 28, 2022
NCT04971070 Completed Analysis of Related Risk Factors of Hypoglycemia Consciousness Disorder July 25, 2021 January 15, 2023
NCT05011682 Completed N/A The Effect of 'Medical Nutrition Therapy' on Post-bariatric Hypoglycemia 2-4 Years After Gastric Bypass Surgery August 27, 2021 December 1, 2021
NCT05076292 Completed N/A Low-dose Glucagon for Prevention of Exercise-Induced Hypoglycemia in People With Type 1 Diabetes November 23, 2021 August 8, 2023
NCT05133765 Completed N/A The SMART B Exercise Study :''The SMART Study'' September 14, 2021 October 7, 2022
NCT05395000 Completed N/A Comparison of Ease of Use and Acceptability of Intranasal and Injectable Glucagon Among Providers Administering it to Children or Adolescents With Type 1 Diabetes (BETTER-ING) March 19, 2021 September 22, 2022
NCT05560789 Completed N/A The Effect of Physical Activity in Individuals With Post-bariatric Hypoglycemia January 3, 2023 March 22, 2024
NCT05569876 Completed N/A The HypoVoice Study November 11, 2022 January 31, 2023
NCT05597605 Completed N/A The SHINE Study: Safety of Implant and Preliminary Performance of the SHINE SYSTEM in Diabetic Subjects September 21, 2022 January 23, 2024
NCT05700604 Completed Hypoglycemia and Glucagon Response in CF January 1, 2020 December 31, 2020
NCT06320730 Completed Impact of Glycemic Control After Reperfusion on Acute Kidney Injury in Living Donor Liver Transplantation August 25, 2020 March 1, 2021
NCT06384118 Completed N/A Effects of a Health Intervention on Hypoglycemic Coping : a Pilot Study August 1, 2023 January 17, 2024
NCT06424574 Completed N/A The Effect of Motivational Interviewing in Children With Type 1 Diabetes July 26, 2021 August 19, 2022
NCT01714895 Completed N/A Effect of Different Plasma Insulin Levels on the Accuracy of Continuous Subcutaneous Glucose Monitoring October 2011 October 2012
NCT01739283 Completed N/A GIP and GLP-1 in Type 1 Diabetes July 2012 November 2013
NCT01816893 Completed N/A Hypoglycemia and Autonomic Nervous System Function June 8, 2004 November 6, 2007
NCT01841359 Completed Phase 4 Pramlintide (Symlin) for the Treatment of Hypoglycemia Following Gastric Bypass Surgery February 2, 2010 February 8, 2022
NCT01852968 Completed Hippocampal Metabolism and Function in Patients With Type 1 Diabetes May 2013 October 31, 2017
NCT01865760 Completed N/A Etiology, Assessment and Treatment of Post-gastric Bypass Severe Hypoglycemia June 2013 March 2016
NCT01897363 Completed Hypoglycemia in Prader-Willi Syndrome July 2013 September 2014
NCT01919788 Completed N/A Intracellular Counter-regulatory Mechanisms Following Low Blood Glucose August 2013 April 2014
NCT01942239 Completed N/A Real-time Continuous Glucose Monitoring in Very Low Birth Weight Neonates December 2008 November 2009
NCT01972152 Completed Phase 2 Safety, Tolerability, Pharmacokinetic (PK) and Pharmacodynamic (PD) Study of G-Pen(TM) (Glucagon Injection) to Treat Severe Hypoglycemia October 2013 February 2014
NCT01980914 Completed N/A Hypoglycemia (Low Blood Sugar) and the Heart March 2015 September 2019
NCT02007278 Completed Phase 4 Glycemic Excursions in Type 2 Diabetic Patients With Vildagliptin and Metformin Versus Vildagliptin and Glimepiride January 3, 2014 February 22, 2016
NCT02056249 Completed Evaluation of the Effect of Hypoglycemia With PET and a Norepinephrine Transporter Ligand June 2011 June 2017
NCT02056353 Completed N/A Multicentre LOGIC-Insulin Algorithm-guided Versus Nurse-directed Blood Glucose Control During Critical Illness (LOGIC-2) February 2014 August 2015
NCT02068638 Completed N/A Impact of Physical Activity on Blood Glucose Stability and Energy Stores in Individuals With Type 1 Diabetes February 2014 July 2016
NCT02081001 Completed Phase 2 PK/PD Study With G-Pump (Glucagon Infusion) in T1DM Patients March 2014 September 2014
NCT02081014 Completed Phase 2 Safety and Efficacy Study of Mini-Dose Glucagon (G-Pen Mini) in Patients With Type 1 Diabetes March 2014 November 2014
NCT02083133 Completed Insulin Dosing in Diabetic Patients With End Stage Renal Disease (ESRD) or Hemodialysis October 1, 2013 May 17, 2017
NCT02086227 Completed Phase 1 Bioequivalence of Fresenius Kabi USA, LLC Glucagon for SC Injection Compared to Glucagon for Injection (Bedford Laboratories) May 2013 June 2013
NCT02171130 Completed Phase 3 Clinical Usability of Intranasal Glucagon in Treatment of Hypoglycemia May 2014 August 2015
NCT02176096 Completed N/A Comparison of the Effect of a Novel Starch (Glycosade) Versus Gastrostomy Tube-Dextrose Infusion on Overnight Euglycaemia Control in Children With Glycogen Storage Disease Type I: Open Label Demonstration Trial July 2014 August 2, 2017
NCT02228642 Completed Hypoglycemia in Hospitalized Patients August 2014 March 2016
NCT02336438 Completed Phase 4 The Effect of Glucomannan Soluble Fiber on Glucose Homeostasis in Patients With Roux En Y (RNY) Gastric Bypass Surgery May 2013 November 2014
NCT02367053 Completed Phase 1 Single Ascending Doses of ZP4207 Administered in HV and in T1D to Evaluate Safety, Tolerability PKs and PDs of ZP4207 Compared to a Comparator December 2014 April 2015
NCT02390141 Completed Phase 1 Multiple Ascending Doses of ZP4207 Administered to HV to Evaluate the Safety, Tolerability, PKs and PDs of ZP4207 April 2015 August 2015
NCT02402933 Completed Phase 3 Clinical Usability of Nasal Glucagon in Treatment of Hypoglycemia in Children and Adolescents March 2015 August 2015
NCT05686590 Enrolling by invitation N/A Prehospital Provider Training With Augmented Reality (AR) December 12, 2022 December 31, 2024
NCT05641792 Not yet recruiting N/A Continuous Glucose Monitoring for Emergency Laparotomy March 15, 2023 December 1, 2025
NCT05990933 Not yet recruiting N/A Role of Adrenaline in in the Inflammatory Response in Diabetes September 2023 October 2024
NCT05870280 Not yet recruiting N/A Nurse Coaching the Effect of on Glycemic Control, Fear of Hypoglycemia and Risk Perception in Adults With Type 1 Diabetes. August 30, 2023 October 30, 2023
NCT05616273 Recruiting Stimulated Glucagon as a Biomarker of Hypoglycemic Risk in Type 1 Diabetes March 23, 2023 September 30, 2025
NCT04207619 Recruiting N/A Evaluating Glial Acetate Metabolism as a Biomarker of Hypoglycemic Counterregulation February 19, 2020 September 2024
NCT05973799 Recruiting N/A Effect of Fasting on Hypoglycemic Counterregulation in Type 1 Diabetes October 10, 2019 December 31, 2024
NCT04192422 Recruiting DiGESTnewborn Study September 1, 2020 December 31, 2025
NCT00992901 Recruiting Early Phase 1 Role of Neural and Hormonal Regulation Factors on Insulin Secretion After Gastric Bypass Surgery October 2009 August 2026
NCT03182192 Recruiting Phase 1 GLP1R-imaging in Hypoglycemia April 1, 2016 July 1, 2024
NCT03385707 Recruiting Hypoglycemia and the Gut Microbiome February 7, 2019 September 2024
NCT06296485 Recruiting N/A Safer Aging With Diabetes Monitoring May 1, 2024 January 31, 2028
NCT05916131 Recruiting N/A Pilot Feasibility Study for HypoPals, a Mobile Health Program for Improving Hypoglycemia Management. September 19, 2023 January 2026
NCT06137586 Recruiting N/A The Effect of Glucose-dependent Insulinotropic Polypeptide on the Alpha Cell Response to Hypoglycaemia in Patients With Type 1 Diabetes August 10, 2022 December 1, 2024
NCT05902104 Recruiting CGM-Assisted Management of PN July 6, 2023 December 2024
NCT06143267 Recruiting N/A Neuronostatin - a Glucagonotropic Agent in Humans? December 6, 2022 August 1, 2024
NCT05378672 Recruiting Phase 3 A Study to Inv. Safety,Efficacy & PD of Dasiglucagon as Hypoglycemia Rescue Therapy in Children<6 Years With T1D May 9, 2023 September 25, 2024
NCT04657783 Recruiting French National Cohort of People With Type 1 Diabetes June 10, 2020 June 10, 2035
NCT05609175 Recruiting Investigating the Relationship Between Nocturnal Glucose Levels and Motion During Sleep February 14, 2023 December 2024
NCT06297980 Recruiting N/A Impact of MEnstruation on Glycemic Response and Exercise In Females With Type 1 Diabetes March 15, 2024 October 31, 2026
NCT05822232 Recruiting N/A FreeStyle Libre 2 Discharge Trial August 17, 2022 April 30, 2024
NCT05379686 Recruiting N/A Low-Dose Glucagon and Advanced Hybrid Closed-Loop System for Prevention of Exercise-Induced Hypoglycaemia in People With Type 1 Diabetes September 21, 2022 May 13, 2024
NCT05711108 Recruiting Continuous Glucose Monitoring (CGM) in Long Term Care (LTC) Facilities January 19, 2022 May 2024
NCT06234787 Recruiting Continuous Subcutaneous Glucose Monitoring in Critical Patients November 30, 2023 December 1, 2027
NCT04797208 Recruiting N/A Remote Glucose Monitoring in Hospital Settings January 9, 2023 August 31, 2023
NCT03867344 Recruiting N/A The Functional Neuroanatomy of the Human Physiological Stress Response October 1, 2019 June 2025
NCT05442853 Recruiting N/A Continuous Glucose Monitoring for Hyperglycemia in Critically Ill Patients November 2, 2022 October 2024
NCT06353217 Recruiting N/A Study of a Primary Care Hypoglycemia Prevention Program May 22, 2024 April 14, 2026
NCT03890432 Recruiting N/A GLUCOSAFE 2 - A New Tool for Nutritional Management and Insulin-therapy in the Intensive Care Unit (ICU) January 10, 2023 November 2023
NCT05447806 Recruiting N/A Diabetes Clinical Decision Support July 15, 2022 May 31, 2026
NCT03508934 Recruiting N/A Continuous Glucose Monitoring Devices in Hospitalized Veterans With Diabetes July 1, 2018 July 11, 2025
NCT00001276 Recruiting Diagnosing and Treating Low Blood Sugar Levels May 21, 1991
NCT05557227 Recruiting N/A Galactose - the Ideal Carbohydrate Supplement for Exercise in Type 1 Diabetes December 15, 2022 June 1, 2024
NCT02445781 Recruiting Early Phase 1 Differing Levels of Hypoglycemia July 2015 December 2025
NCT06246578 Recruiting N/A Concordance of Hypoglycemia Measurement With Simultaneous Use of Two Devices for Continuous Glucose Measurement. January 19, 2024 August 1, 2024
NCT05933161 Recruiting A Study of Glycemic Control in Left Ventricular Assist November 10, 2023 July 2025
NCT05643144 Recruiting N/A Enhancing Shared Decision-making to Guide Care for People With Dementia and Diabetes June 7, 2023 August 17, 2026
NCT05640947 Recruiting N/A Endoscopic Ultrasound-guided Large Diameter Lumen-apposing Metal Stent Gastro-gastrostomy for Bypass Reversal in Patients With Roux-en-y Gastric Bypass January 30, 2023 February 2026
NCT04874532 Suspended N/A A Study to Improve Diabetes Management Among Adults Experiencing Severe Hypoglycemia June 4, 2021 December 31, 2024
NCT00490893 Terminated Phase 4 Hypoglycemia Counterregulation and Symptom Perception With Insulin Detemir March 2006 December 2006
NCT04854135 Terminated N/A Continuous Glucose Monitoring Initiation at Hospital Discharge April 13, 2021 June 13, 2022
NCT05007977 Terminated Phase 1 Effect of ZT-01 on Glucagon During Hypoglycemia in Type 1 Diabetes Mellitus July 8, 2021 April 18, 2022
NCT03748433 Terminated N/A Assessment of the Impact of Real-Time Continuous Glucose Monitoring on People Presenting With Severe Hypoglycaemia January 3, 2019 September 9, 2021
NCT02300285 Terminated N/A Efficacy of Continuous Glucose Monitoring in Neonates With Hypoglycemia February 2015 August 30, 2018
NCT04026750 Terminated Phase 1 Insulin Tolerance Test Study in Patients With Type 1 Diabetes September 15, 2019 February 16, 2020
NCT04085978 Terminated Effects of a Hypoglycemia Protocol With Glucose Gel on Neonatal Intensive Care Unit (NICU) Admission May 4, 2020 October 12, 2020
NCT02682940 Terminated N/A T1 Diabetes Hypoglycemia Prevention Pilot May 2016 December 2016
NCT02733848 Terminated Phase 1 CREON for the Treatment of Post-RYGB Hypoglycemia February 2014 January 31, 2018
NCT00869414 Terminated N/A Glycemic Effects of Morning Only, Evening Only or Twice Daily Insulin Glargine in Patients With Type 1 Diabetes July 2009 March 2010
NCT00798590 Terminated Phase 2 The Efficacy of Glucagon Like Peptide (GLP) - 1(7-36) Amide for Glycemic Control in Critically Ill Patients December 2008 June 2011
NCT00766441 Terminated Phase 4 Sitagliptin Versus Sulphonylurea in Type 2 Diabetes During Ramadan August 2008 October 2009
NCT02906891 Terminated N/A A Pilot Study of Nocturnal Hypoglycemia Prevention in Type 1 Diabetes Using the Vigilant Diabetes Management Companion May 2016 December 2016
NCT03020264 Terminated N/A Frequency of Hypoglycemia in Patients With Type 2 Diabetes Under Insulin Therapy Older Than 75 Years in Real Life November 28, 2017 June 18, 2020
NCT00672204 Terminated Phase 1/Phase 2 Raptiva and Sirolimus in Islet Transplantation for Type 1 Diabetes November 2007 August 2012
NCT03107806 Terminated N/A Monitoring Glucose Levels in Patients With Myocardial Infarction April 2013 January 2018
NCT03246243 Terminated Quantitative Assessment of Sucking for Early Diagnosis of Brain Injury in Infants at High Risk March 29, 2017 May 18, 2021
NCT01238016 Terminated N/A Evaluation of Hypo-Safe Hypoglycaemia Alarm Device - a Pilot Study November 2010 August 2014
NCT01225159 Terminated N/A Tight Glycaemic Control During Cardiac Surgery September 2008 March 2009
NCT04926298 Unknown status Glycemic Control Before, During and After the 2016 Paris Marathon August 15, 2020 July 1, 2021
NCT02909881 Unknown status N/A Dose Response Oxidation of a Sweet-corn Derived Sugar (PhytoSpherix) During Exercise in Endurance Trained Athletes September 2016 September 2017
NCT01525784 Unknown status Affect of RT-CGMS as Part of Clinical Care in Type 1 Diabetes Mellitus Patients February 2012 June 2014
NCT05087225 Unknown status Suspicion of Hypoglycemic Effect of mRNA Based Covid-19 Vaccines (Polyethylene Glycol) Will Happen , Observational Study on Diabetic Patients at Saudia Arabia November 11, 2021 April 1, 2022
NCT00550069 Unknown status Observational Study of Infants Born at 34 to 37 Weeks of Gestation Until the Age of 1 Year December 2007 January 2009
NCT03702959 Unknown status Antenatal Betamethasone and the Risk of Neonatal Hypoglycemia October 1, 2018 March 1, 2020
NCT04172116 Unknown status Continuous Glucose Monitoring (CGM) After Surgical Variations of the Roux-en-y Gastric Bypass January 2020 January 2021
NCT04997460 Unknown status Diabetes Type One in Pregnancy and Continuos Glucose Monitoring January 11, 2021 January 11, 2024
NCT02550145 Unknown status Phase 1 Role of GLP-1 in Hyperinsulinemic Hypoglycemia Post-bariatric Surgery February 2014
NCT00506272 Unknown status N/A Inpatient Self Monitoring and Administration Study (ISMAS) December 2007
NCT02380339 Unknown status N/A A Combined Biofeedback-virtual Reality System for Reduction of Fear of Hypoglycemia March 1, 2018 December 2019
NCT01301053 Unknown status N/A Pilot Study of Intensive Care Unit Continuous Glucose Monitoring February 2011 September 2013
NCT03802942 Unknown status Phase 3 Prevention of Hypoglycemia Among Diabetes Patients Admitted to Internal Medicine Departments With Nutritional Care July 1, 2019 December 2023
NCT00678145 Unknown status Phase 2 Mechanisms of Hypoglycemia Associated Autonomic Failure March 2008 August 2022
NCT00994149 Unknown status Phase 2/Phase 3 Diazoxide In the Management Of Hypoglycemic Neonates October 2009 October 2011
NCT04595383 Unknown status N/A Electronic Platform for Diabetic Patients Activation October 1, 2021 May 31, 2022
NCT03827434 Withdrawn N/A CGM/Clarity Use, Glycemic Control and Clinical Outcomes December 1, 2018 October 31, 2019
NCT00279851 Withdrawn Blood Sugars in Children With Idiopathic Seizures. February 2006 February 2007
NCT01029639 Withdrawn Phase 2/Phase 3 Effects of Pulsatile Intravenous Insulin Delivery on Hypoglycemic Unawareness January 2007 August 2009
NCT04192019 Withdrawn Early Phase 1 Micro Glucagon During Exercise in Type 1 Diabetes April 2023 June 2024
NCT02518022 Withdrawn N/A How to be Safe With Alcoholic Drinks in Diabetes September 2015 June 2016
NCT04824872 Withdrawn Phase 2 Efficacy and Safety of Dasiglucagon for Treatment of Post-bariatric Hypoglycemia in Roux-en-Y Gastric Bypass (RYGB) Operated Adults February 2023 February 2023
NCT03736083 Withdrawn N/A Introducing CGM at Type 1 Diabetes Diagnosis September 2019 October 2020
NCT01387477 Withdrawn Phase 4 Lactate to Treat Hypoglycemia June 2011 June 2012
NCT02586831 Withdrawn Phase 1/Phase 2 Diabetes Islet Preservation Immune Treatment January 2025 December 2029
Disase is a (Disease Ontology)
DOID:4194
Cross Reference ID (Disease Ontology)
ICD10CM:E16.2
Cross Reference ID (Disease Ontology)
ICD9CM:251.2
Cross Reference ID (Disease Ontology)
MESH:D007003
Cross Reference ID (Disease Ontology)
NCI:C3126
Cross Reference ID (Disease Ontology)
SNOMEDCT_US_2023_03_01:154691006
Cross Reference ID (Disease Ontology)
UMLS_CUI:C0020615
Exact Synonym (Disease Ontology)
Hypoglycaemia
HPO alt_id (Human Phenotype Ontology)
HP:0003356
HPO Human Phenotype ID (Human Phenotype Ontology)
HP:0001943
MedGen concept unique identifier (MedGen Concept name)
C0020615
MedGen unique identifier (MedGen Concept name)
6979
MeSH unique ID (MeSH (Medical Subject Headings))
D007003